{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:42:59Z","timestamp":1777930979187,"version":"3.51.4"},"reference-count":23,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["New Solut"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:p>Leidos, Inc. is a large government science and technology company. When a Leidos employee lost his son to an opioid overdose, he wrote an impassioned email to the CEO, asking him to take action related to the growing societal problem of opioid use disorders. The CEO understood and accepted this important call to action. Leidos\u2019 subsequent efforts included supporting employees and families, as well as community outreach, eventually broadening to include mental health and well-being. This paper outlines the company\u2019s efforts to combat opioid use disorders, understanding that they sit within a larger total worker health umbrella inclusive of mental health and well-being. The hope is that this ongoing journey and its exemplars are helpful for other organizations seeking to make an impact for their employees and society.<\/jats:p>","DOI":"10.1177\/10482911211037573","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T23:52:34Z","timestamp":1628207554000},"page":"229-238","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Answering a Call to Action on American Workplace and Community Opioid Concerns"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0375-7880","authenticated-orcid":false,"given":"Peter","family":"Harnett","sequence":"first","affiliation":[{"name":"Leidos Inc., Reston, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hindman","sequence":"additional","affiliation":[{"name":"Leidos Inc., Reston, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Duenas","sequence":"additional","affiliation":[{"name":"Leidos Inc., Reston, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Coogan","sequence":"additional","affiliation":[{"name":"Leidos Inc., Reston, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Misicko","sequence":"additional","affiliation":[{"name":"Leidos Inc., Reston, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"bibr1-10482911211037573","volume-title":"The evidence for stigma change, committee on the science of changing behavioral health social norms; board on behavioral, cognitive, and sensory sciences; division of behavioral and social sciences and education; national academies of sciences, engineering, and medicine","author":"Ending Discrimination Against People with Mental and Substance Use Disorders","year":"2016"},{"key":"bibr2-10482911211037573","unstructured":"National Safety Council. Substance Use Employer Calculator for Employers, www.nsc.org\/forms\/substance-use-employer-calculator (2021, accessed 30 May 2021)."},{"key":"bibr3-10482911211037573","doi-asserted-by":"publisher","DOI":"10.1186\/s40991-018-0039-y"},{"key":"bibr4-10482911211037573","unstructured":"Technical Task Force of the International Integrated Reporting Council (IIRC) Technical Collaboration Group. Forum for the future, the five capitals \u2013 a framework for sustainability, https:\/\/integratedreporting.org\/wp-content\/uploads\/2013\/03\/IR-Background-Paper-Capitals.pdf (2013, accessed 2 June 2021)."},{"key":"bibr5-10482911211037573","unstructured":"Governance, Business Roundtable, Our commitment, https:\/\/opportunity.businessroundtable.org\/ourcommitment\/; Corporate governance \u2013 business roundtable redefines the purpose of a corporation to promote \u201can economy that serves all americans,\u201d www.businessroundtable.org\/business-roundtable-redefines-the-purpose-of-a-corporation-to-promote-an-economy-that-serves-all-americans (2019, accessed 2 June 2021)."},{"key":"bibr6-10482911211037573","unstructured":"NIOSH. Workplace supported recovery, www.cdc.gov\/niosh\/topics\/opioids\/wsrp\/default.html (2020, accessed 14 April 2021)."},{"key":"bibr7-10482911211037573","unstructured":"Department of Health and Human Services\/SAMSHA. Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health, www.samhsa.gov\/data\/sites\/default\/files\/cbhsq-reports\/NSDUHNationalFindingsReport2018\/NSDUHNationalFindingsReport2018.pdf (2019, accessed 14 April 2021)."},{"key":"bibr8-10482911211037573","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e3181b01710"},{"key":"bibr9-10482911211037573","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.23029"},{"key":"bibr10-10482911211037573","unstructured":"Davis L, Hawkins D, Laing J. Opioid-related overdose deaths in Massachusetts by industry and occupation, 2011-2015: implications for Prevention, www.niehs.nih.gov\/news\/events\/pastmtg\/hazmat\/assets\/2018\/wtp_fall_18_letitia_tish_davis.pdf (2018, accessed 2 June 2021)."},{"key":"bibr11-10482911211037573","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.3365"},{"key":"bibr12-10482911211037573","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2019.11.006"},{"key":"bibr13-10482911211037573","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2014.0234"},{"key":"bibr14-10482911211037573","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2015.1127870"},{"key":"bibr15-10482911211037573","unstructured":"NIDA. Opioid overdose crisis, www.drugabuse.gov\/drug-topics\/opioids\/opioid-overdose-crisis (2021, accessed 31 May 2021)."},{"key":"bibr16-10482911211037573","unstructured":"NIDA. Benzodiazepines and opioids, www.drugabuse.gov\/drug-topics\/opioids\/benzodiazepines-opioids (2021, accessed 30 May 2021)."},{"key":"bibr17-10482911211037573","unstructured":"NIDA. Opioid overdose reversal with naloxone (Narcan, Evzio), www.drugabuse.gov\/drug-topics\/opioids\/opioid-overdose-reversal-naloxone-narcan-evzio (2020, accessed 31 May 2021)."},{"key":"bibr18-10482911211037573","first-page":"632","volume":"152","author":"Goulder MA","year":"2011","journal-title":"J Autism Dev Disord"},{"key":"bibr19-10482911211037573","unstructured":"Substance Abuse and Mental Health Services Administration: Center for Behavioral Health Statistics and Quality. Results from the 2019 National Survey on Drug Use and Health: detailed tables, Table 1.61 A,B. 2018\u20142019, www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt29394\/NSDUHDetailedTabs2019\/NSDUHDetailedTabs2019.htm (2020, accessed 11 July 2021)."},{"key":"bibr20-10482911211037573","first-page":"2968","volume":"10","author":"Bozorg BD","year":"2020","journal-title":"Nature Sci Rep"},{"key":"bibr21-10482911211037573","unstructured":"CDC\/Division of HIV\/AIDS Prevention. Managing HIV and hepatitis C outbreaks among people who inject drugs: guide for state and local health departments, www.cdc.gov\/hiv\/pdf\/programresources\/guidance\/cluster-outbreak\/cdc-hiv-hcv-pwid-guide.pdf (2018, accessed 18 June 2021)."},{"key":"bibr22-10482911211037573","unstructured":"NIOSH. Fundamentals of total worker health approaches: essential elements for advancing worker safety, health, and well-being, www.cdc.gov\/niosh\/docs\/2017-112\/ (2016, accessed 1 June 2021)."},{"key":"bibr23-10482911211037573","unstructured":"NIOSH. Total worker health \u2013 priority areas and emerging issues, www.cdc.gov\/niosh\/twh\/priority.html (2020, accessed 1 June 2021)."}],"container-title":["NEW SOLUTIONS: A Journal of Environmental and Occupational Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10482911211037573","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10482911211037573","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10482911211037573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:30:40Z","timestamp":1777681840000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10482911211037573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1177\/10482911211037573"],"URL":"https:\/\/doi.org\/10.1177\/10482911211037573","relation":{},"ISSN":["1048-2911","1541-3772"],"issn-type":[{"value":"1048-2911","type":"print"},{"value":"1541-3772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]}}}